Decrease of CA 19-9 in patients with advanced pancreatic cancer (APC) undergoing chemotherapy predicts survival time

K. Pohlank,A. Hilbig,Uwe Pelzer,Jens Stieler,L. Roll,A. Goerke,Marianne Sinn,Bernd Dörken,Hanno Riess,Helmut Oettle

Decrease of CA 19-9 in patients with advanced pancreatic cancer (APC) undergoing chemotherapy predicts survival time

2008

K. Pohlank
A. Hilbig
Uwe Pelzer
Jens Stieler
L. Roll
A. Goerke
Marianne Sinn
Bernd Dörken
Hanno Riess
Helmut Oettle

15574 Background: Serum carbohydrate antigen 19–9 (CA 19–9), the sialylated Lewis a blood group antigen has been shown to be a very sensitive and specific serum marker for pancreatic cancer. The pr...

Keywords:

Pathology
CA19-9
Pancreatic cancer
Cancer research
Internal medicine
Chemotherapy
Oncology
Medicine
in patient
Gastroenterology
blood group antigens
Carbohydrate antigen
serum markers

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations